Clinical Trial Update: First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01) [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of DS-1062a for advanced solid tumors, including breast cancer subtypes and non-small cell lung cancer, is underway; the trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• DS-1062a (datopotamab deruxtecan)

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Hormone Receptor Positive Breast Cancer, Triple Negative Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING